O6-methylguanine-DNA methyltransferase (MGMT), a DNA repair enzyme and downstream effector of the HH cascade, has been reported to significantly contribute to the development of drug resistance in both glioma and glioblastoma [172]. Here, MGMT is linked to glioma.